Evidence map›Paper›PMID 42746496›Full record

ArticleFrontiers in psychiatry2026

Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD.

Gabrielle Agin-Liebes, Sarah Shnayder, Geena Fram, Thomas Cody Swift, Terence Ching, Anastasia Jankovsky, Jamila Hokanson, Christopher Pittenger, Benjamin Kelmendi

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gabrielle Agin-LiebesDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
Sarah ShnayderDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
Geena FramDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
Thomas Cody SwiftRiverStyx Foundation, Santa Cruz, CA, United States.
Terence ChingDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
Anastasia JankovskyEastern Michigan University, Ypsilanti, MI, United States.
Jamila HokansonDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
Christopher PittengerDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.
Benjamin KelmendiDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Psilocybin treatment has shown promise for treatment-resistant obsessive-compulsive disorder (OCD), yet clinical response is variable. Little is known about the subjective experiences associated with divergent outcomes or the psychological processes differentiating responders from non-responders. Materials and methods: A qualitative case comparison was conducted using semi-structured interviews from six participants enrolled in a randomized controlled trial of single-dose psilocybin with psychological support for treatment-resistant OCD. Participants were purposively selected to contrast three responders with marked symptom improvement and three non-responders with minimal improvement or worsening symptoms. Interviews were conducted approximately 1-2 months post-dosing and analyzed using reflexive thematic analysis. Results: Four dialectical themes captured key contrasts between responders and non-responders: 1) Surrender vs. Control, 2) Disidentification with OCD and Self-Compassion vs. Overidentification with OCD, 3) Emotional Breakthrough vs. Emotional Containment, and 4) Reappraisal of OCD as Inconsequential vs. Sustained Conviction in OCD. Among responders, surrender during the acute session appeared to enable subsequent psychological shifts. The self was separated from OCD while self-compassion was developed; emotions were experienced directly in the body without the usual cognitive filtering; and OCD-related concerns were spontaneously reappraised as arbitrary and inconsequential. Among non-responders, control was maintained or surrender was experienced as overwhelming; identification with OCD and persistent self-criticism remained; difficult emotions were avoided or accessed without lasting breakthrough; and conviction in OCD's logic and demands was maintained or intensified. Discussion: The distinction between intellectual insight and embodied change emerged as central: responders described viscerally felt insights that spontaneously shaped behavior, whereas non-responders articulated understanding without corresponding change in feeling or action. Across themes, surrender during the acute session appeared to enable subsequent shifts in self-concept, emotional processing, and reappraisal of OCD as inconsequential. Therapeutic benefit may depend on the quality of psychological engagement-particularly the capacity to surrender, tolerate intense emotion, and translate insight into behavioral change-rather than experiential intensity alone. The distinction between intellectual insight and embodied change emerged as central to understanding differential response.

Indexed as

clinical trialintegrationmechanismnon-responseobsessive-compulsive disorderpsilocybinpsychedelicqualitative

Identifiers

PMID42746496
PMCPMC13576466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.